Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer
暂无分享,去创建一个
Wenyun Jia | Baolan Li | Qiankun Zhang | Zan Liu | J. Hao | Tongmei Zhang | Hua Zheng | Yuan Gao | Jie Li | Ying Hu | Zhe Qian | A. Hu
[1] K. Miyazono,et al. Long noncoding RNA NORAD regulates transforming growth factor‐β signaling and epithelial‐to‐mesenchymal transition‐like phenotype , 2018, Cancer science.
[2] E. Richardsen,et al. Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer , 2018, Scientific Reports.
[3] Gang Li,et al. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] Y. Huang,et al. Risk Factors Associated With Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Stage I Non–Small Cell Lung Cancer , 2017, Technology in cancer research & treatment.
[5] G. Zhai,et al. SMAD3 Is Upregulated in Human Osteoarthritic Cartilage Independent of the Promoter DNA Methylation , 2016, The Journal of Rheumatology.
[6] A. Bode,et al. 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells , 2015, Oncotarget.
[7] Hui Li,et al. MicroRNA-7 inhibits the malignant phenotypes of non‑small cell lung cancer in vitro by targeting Pax6. , 2015, Molecular medicine reports.
[8] Xiangxian Zhang,et al. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. , 2015, International journal of clinical and experimental pathology.
[9] Xiangdong Li,et al. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer. , 2015, Oncology reports.
[10] Shu-Lin Liu,et al. Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases , 2015, PloS one.
[11] L. Tanoue,et al. Lung cancer screening. , 2015, American journal of respiratory and critical care medicine.
[12] D. Dhall,et al. Comparison of PAX6 and PAX8 as Immunohistochemical Markers for Pancreatic Neuroendocrine Tumors , 2015, Endocrine pathology.
[13] P. Iyengar,et al. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] X. Chen,et al. Effects of Smad3 on the proliferation and steroidogenesis in human ovarian luteinized granulosa cells , 2014, IUBMB life.
[15] T. Spector,et al. SMAD3 Is Associated with the Total Burden of Radiographic Osteoarthritis: The Chingford Study , 2014, PloS one.
[16] Lei Zhan,et al. Methylated +58CpG site decreases DCN mRNA expression and enhances TGF-β/Smad signaling in NSCLC cells with high metastatic potential. , 2014, International journal of oncology.
[17] Yue Wang,et al. Downregulation of PAX6 by shRNA Inhibits Proliferation and Cell Cycle Progression of Human Non-Small Cell Lung Cancer Cell Lines , 2014, PloS one.
[18] Yuehui Li,et al. PAX6, a Novel Target of microRNA-7, Promotes Cellular Proliferation and Invasion in Human Colorectal Cancer Cells , 2014, Digestive Diseases and Sciences.
[19] B. Loo,et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. , 2012, Chest.
[20] R. Ashery-Padan,et al. Pax6: A multi-level regulator of ocular development , 2012, Progress in Retinal and Eye Research.
[21] D. Carbone,et al. Smoking Attenuates Transforming Growth Factor-β–Mediated Tumor Suppression Function through Downregulation of Smad3 in Lung Cancer , 2012, Cancer Prevention Research.
[22] J. Jonas,et al. Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. , 2011, Investigative ophthalmology & visual science.
[23] Peter Devilee,et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers , 2010, Breast Cancer Research.
[24] Rajnikant Mishra,et al. Interaction of Pax6 with SPARC and p53 in Brain of Mice Indicates Smad3 Dependent Auto-regulation , 2010, Journal of Molecular Neuroscience.
[25] Terje Johansen,et al. The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter , 2007, Nucleic acids research.